Treatment Advancements in Atopic Dermatitis With JAK Inhibitors: Updates for Pharmacists | PTCE Pharmacy Connect
PTCE Pharmacy Connect | Pharmacy Times11/30/22 • 31 min
The educational objectives are: • Review the pathophysiology of atopic dermatitis (AD) as well as the efficacy and safety data for topical JAK inhibitors that are approved and in development • Discuss the role of pharmacists as a part of the care team for patients with AD as well as the key counseling points and monitoring parameters Faculty: Dennis Williams Moderator: Jamie McConaha
11/30/22 • 31 min
Generate a badge
Get a badge for your website that links back to this episode
Select type & size
<a href="https://goodpods.com/podcasts/ptce-pharmacy-connect-pharmacy-times-260035/treatment-advancements-in-atopic-dermatitis-with-jak-inhibitors-update-30674589"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to treatment advancements in atopic dermatitis with jak inhibitors: updates for pharmacists | ptce pharmacy connect on goodpods" style="width: 225px" /> </a>
Copy